Contact UsInvestorsCareersMediaScienceContact Us
HomeProductsPrescription MedicinesZinforo

This page is intended as reference information for the general public.

Zinforo® (ceftaroline fosamil)

What is Zinforo and what is it used for?

Zinforo is an antibiotic medicine, available in the UK from Pfizer. It works by killing certain types of bacteria which can cause serious infections.

It is recognised that some types of bacteria which make us ill, are becoming resistant to antibiotics making them difficult to treat. Therefore, there are a range of different antibiotics available to try and combat this resistance; Zinforo is one of these.

Zinforo is used to treat children (from birth) and adults with:

  • infections of the skin and the tissues below the skin

  • an infection of the lungs called ‘pneumonia’

Medical professionals carefully consider a range of factors before recommending which antibiotic to use.

Zinforo 600mg is given via a drip into a vein, usually in hospital. It is only available with a prescription.


Reference Information

Medicines in Northern Ireland fall under the remit of the European Medicines Agency (EMA) whilst medicines in Great Britain (England, Scotland and Wales) fall under the remit of the Medicines and Healthcare products Regulatory Agency (MHRA) following the UK leaving the European Union. These agencies are responsible for the scientific evaluation, supervision and safety monitoring of medicines developed by pharmaceutical companies.

If you would like to see the Summary of Product Characteristics (SPC) or Patient Information Leaflet (PIL) for Zinforo please follow these links:

Great Britain
Zinforo (ceftaroline fosamil)

Northern Ireland
Zinforo (ceftaroline fosamil)

Pfizer is unable to provide advice on personal medical matters. Please consult your doctor or other relevant health professional for specific, health-related advice and support.

If you get any side effects when taking this or any other medicine, talk to your doctor or other relevant health professional e.g. pharmacist, nurse. This includes any possible side effects not listed in the packaging leaflet. You can also report side effects directly via the Yellow Card Scheme at or search the Google Play or Apple App Store for MHRA Yellow Card. By reporting side effects, you can help provide more information on the safety of this medicine.

PP-ZFO-GBR-0266 / February 2023
Science Products Responsibility PartnershipsCareers Privacy Statement Terms of Use Contact UsSitemap Copyright © 2017-2024 Pfizer Limited. PP-UNP-GBR-8108 / January 2024. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427. This website is intended for the general public in the UK.